curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 8,000.00
-190.00 (-2.32%)
At close: Nov 5, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 177.26 billion as of November 5, 2026. It is the 23,092nd most valuable company in the world and the 853rd biggest in South Korea. Its market cap has increased by 53.40% in one year.
Market Cap
177.26B
Enterprise Value
165.40B
Revenue
8.24B
Global Rank
Country Rank
#853 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 177.26B, a decrease of -56.70%. That is a compound annual growth rate of -14.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 177.26B | 18.33% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 232.96B |
| HansBiomed | 227.47B |
| IntoCell | 218.42B |
| Genome & Company | 188.80B |
| IMBiologics | 183.53B |
| Kangstem Biotech | 175.79B |
| NIBEC | 150.86B |
| ISU Abxis | 136.60B |